Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ascending-Dose, Double-Blind, Placebo-Controlled, Bilateral Study of Intralesional Fluphenazine Decanoate in Psoriasis

NCT00356200 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT00356200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00356200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ascending-Dose, Double-Blind, Placebo-Controlled, Bilateral Study of Intralesional Fluphenazine Decanoate in Psoriasis
Lead sponsor
Tufts Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2006
Completion date
September 30, 2008
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis